Ultralife Corporation Update on Form 12b-25 Submission
NEWARK, N.Y. — Ultralife Corporation (NASDAQ: ULBI) has officially submitted a Form 12b-25 notification, indicating a late filing with the Securities and Exchange Commission concerning its Annual Report on Form 10-K for the fiscal year ending December 31, 2024.
Reason for Late Filing Notification
The need for an extension arises to ensure all financial results and accounting closures are meticulously completed, particularly concerning the audit of Electrochem Solutions, Inc. This company was acquired by Ultralife on October 31, 2024. The corporation plans to file its 10-K as promptly as possible, ideally by April 1, 2025, in compliance with Rule 12b-25.
Impact on Earnings Release Schedule
As a consequence of this delay, Ultralife is also rescheduling its earnings release alongside its conference call for the fourth quarter and fiscal year 2024. The initial date was set for Tuesday, March 11, 2025. The new date and time for the earnings release and corresponding call will be confirmed following the filing of the Form 10-K.
Overview of Ultralife Corporation
Ultralife Corporation is dedicated to delivering high-quality products and services that span from power solutions to sophisticated communications and electronics systems. With a robust engineering background and a collaborative problem-solving approach, the company effectively serves both government/defense and commercial sectors worldwide.
Business Operations
The company's headquarters are located in Newark, New York, and its operations include two significant business segments: Battery & Energy Products and Communications Systems. Ultralife has established a solid presence across North America, Europe, and Asia, emphasizing its commitment to innovation and quality.
Contact Details for Shareholders
For inquiries, shareholders can reach out to Ultralife Corporation through Philip A. Fain at (315) 210-6110 or via email at pfain@ulbi.com. Investors can contact Alliance Advisors IR, represented by Jody Burfening or Alex Villalta, at (212) 838-3777 or through avillalta@allianceadvisors.com.
Frequently Asked Questions
What is the purpose of Form 12b-25?
Form 12b-25 is used by companies to notify the Securities and Exchange Commission of a late filing for their annual reports.
Why did Ultralife Corporation file a late notification?
The delay is attributed to the ongoing audit and accounting processes related to the acquisition of Electrochem Solutions, Inc.
When will the new earnings release date be announced?
The date for the rescheduled earnings release will be confirmed once the Form 10-K is officially filed.
What segments does Ultralife Corporation operate in?
Ultralife operates primarily in two sectors: Battery & Energy Products and Communications Systems, catering to various markets.
How can investors get in contact for inquiries?
Investors can contact Ultralife Corporation directly via phone or email for any queries regarding the company.
